Clinical Trial

Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration

Study acronym: SERENE
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-23
notable Primary completion pushed: 2026-06-01 -> 2026-07-01 2026-05-23
minor Completion pushed: 2026-06-01 -> 2026-07-01 2026-05-23
Trial Details
NCT Number NCT07269808
Lead Sponsor Massachusetts General Hospital
Conditions Anesthesia, Sedation, Endoscopy
Enrollment 100 participants
Start Date 2026-03-03
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-22